Cas no 158930-09-7 ((3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide, butanedioic acid)
(3R)-3-(Methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide, as the free base or in combination with butanedioic acid (succinic acid), is a chiral carbazole derivative with potential pharmacological applications. The (3R)-enantiomer exhibits stereospecificity, which may enhance binding affinity and selectivity in biological systems. The carboxamide moiety improves solubility and stability, while the tetrahydrocarbazole scaffold offers a rigid structure for molecular interactions. When formulated as a succinate salt, the compound benefits from improved crystallinity and bioavailability. This combination is particularly advantageous in drug development, where controlled release and enhanced pharmacokinetic properties are desired. The product is suitable for research in central nervous system (CNS) targeting or enzyme inhibition studies due to its structural features.
158930-09-7 structure
Product Name:(3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide, butanedioic acid
CAS No:158930-09-7
MF:C18H23N3O5
MW:361.39232468605
MDL:MFCD08141809
CID:847189
PubChem ID:152944
Update Time:2025-05-28
(3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide, butanedioic acid Chemical and Physical Properties
Names and Identifiers
-
- Frovatriptan succinate
- butanedioic acid,(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide
- AC1L49EJ
- CHEMBL1200371
- CTK0H6296
- Frovatriptan succinate anhydrous
- SB 209509ax
- SB-209509ax
- SB-209509-AX
- SureCN672784
- (3R)-2,3,4,9-Tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide butanedioate
- Vml 251
- Fovatriptan succinate
- (R)-3-(Methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide succinate
- 1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (R)-, butanedioate (1:1)
- 1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (3R)-, butanedioate (1:1)
- Butanedioic acid, compd. with (3R)-2,3,4,9-tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide (1:1)
- (3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide, butanedioic acid
-
- MDL： MFCD08141809
- Inchi： 1S/C14H17N3O.C4H6O4/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13;5-3(6)1-2-4(7)8/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18);1-2H2,(H,5,6)(H,7,8)/t9-;/m1./s1
- InChI Key： WHTHWNUUXINXHN-SBSPUUFOSA-N
- SMILES： O=C(C1C=CC2=C(C=1)C1=C(CC[C@H](C1)NC)N2)N.OC(CCC(=O)O)=O
(3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide, butanedioic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A449038121-5g |
(R)-3-(Methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide succinate |
158930-09-7 | 97% | 5g |
472.50 USD | 2021-06-15 | |
| Alichem | A449038121-10g |
(R)-3-(Methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide succinate |
158930-09-7 | 97% | 10g |
772.50 USD | 2021-06-15 | |
| S e l l e c k ZHONG GUO | S5848-25mg |
Frovatriptan Succinate |
158930-09-7 | 99.96% | 25mg |
￥877.11 | 2023-09-15 | |
| DC Chemicals | DC20208-100 mg |
Frovatriptan Succinate |
158930-09-7 | >98% | 100mg |
$150.0 | 2022-02-28 | |
| DC Chemicals | DC20208-250 mg |
Frovatriptan Succinate |
158930-09-7 | >98% | 250mg |
$300.0 | 2022-02-28 | |
| DC Chemicals | DC20208-1 g |
Frovatriptan Succinate |
158930-09-7 | >98% | 1g |
$600.0 | 2022-02-28 | |
| S e l l e c k ZHONG GUO | S5848-1g |
Frovatriptan Succinate |
158930-09-7 | 99.96% | 1g |
￥10401.3 | 2023-09-15 | |
| DC Chemicals | DC20208-100mg |
Frovatriptan Succinate |
158930-09-7 | >98% | 100mg |
$150.0 | 2023-09-15 | |
| DC Chemicals | DC20208-250mg |
Frovatriptan Succinate |
158930-09-7 | >98% | 250mg |
$300.0 | 2023-09-15 | |
| DC Chemicals | DC20208-1g |
Frovatriptan Succinate |
158930-09-7 | >98% | 1g |
$600.0 | 2023-09-15 |
(3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide, butanedioic acid Related Literature
-
Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
-
Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
-
Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
-
Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
-
Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
158930-09-7 ((3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide, butanedioic acid) Related Products
- 158747-02-5((3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide)
- 158930-17-7(Frovatriptan succinate hydrate)
- 158930-18-8(ent-Frovatriptan)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
Recommended suppliers
Zouping Mingyuan Import and Export Trading Co., Ltd
Gold Member
Audited Supplier
CN Supplier
Reagent
Essenoi Fine Chemical Co., Limited
Gold Member
Audited Supplier
CN Supplier
Reagent
鉅瀾化工科技(青島)有限公司
Gold Member
Audited Supplier
CN Supplier
Bulk
Hunan Well Medicine Synthesis Technology Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Reagent
TAIXING JOXIN BIO-TEC CO.,LTD.
Gold Member
Audited Supplier
CN Supplier
Bulk
